Apr 292020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation devices for the treatment of urinary and bowel dysfunction, announced today the appointment of Michael Carrel as Chairman of the Axonics' Board of Directors. Concurrent with ...

Axonics Modulation Technologies appoints Board member Mike Carrel as Chairman of the Board of Directors

Axonics Modulation Technologies appoints Board member Mike Carrel as Chairman of the Board of Directors

From:: Axonics Modulation Technologies appoints Board member Mike Carrel as Chairman of the Board of Directors

Sorry, the comment form is closed at this time.